Cogstate Ltd (AU:CGS) — Market Cap & Net Worth
Market Cap & Net Worth: Cogstate Ltd (CGS)
Cogstate Ltd (AU:CGS) has a market capitalization of $291.33 Million (AU$411.73 Million) as of May 4, 2026. Listed on the AU stock exchange, this Australia-based company holds position #15085 globally and #412 in its home market, demonstrating a -0.83% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cogstate Ltd's stock price AU$2.40 by its total outstanding shares 171554424 (171.55 Million). Analyse Cogstate Ltd (CGS) cash flow conversion to see how efficiently the company converts income to cash.
Cogstate Ltd Market Cap History: 2015 to 2026
Cogstate Ltd's market capitalization history from 2015 to 2026. Data shows growth from $70.96 Million to $291.33 Million (21.91% CAGR).
Cogstate Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cogstate Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
5.40x
Cogstate Ltd's market cap is 5.40 times its annual revenue
Latest Price to Earnings (P/E) Ratio
27.04x
Cogstate Ltd's market cap is 27.04 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $147.35 Million | $27.25 Million | $2.64 Million | 5.41x | 55.77x |
| 2017 | $107.05 Million | $35.01 Million | -$853.06K | 3.06x | N/A |
| 2018 | $72.16 Million | $37.37 Million | -$730.37K | 1.93x | N/A |
| 2019 | $47.34 Million | $30.53 Million | -$3.49 Million | 1.55x | N/A |
| 2020 | $133.52 Million | $33.97 Million | -$2.92 Million | 3.93x | N/A |
| 2021 | $293.75 Million | $43.82 Million | $7.02 Million | 6.70x | 41.87x |
| 2022 | $237.92 Million | $62.03 Million | $10.37 Million | 3.84x | 22.94x |
| 2023 | $175.40 Million | $60.14 Million | $5.30 Million | 2.92x | 33.07x |
| 2024 | $126.85 Million | $66.27 Million | $5.45 Million | 1.91x | 23.28x |
| 2025 | $274.33 Million | $50.81 Million | $10.14 Million | 5.40x | 27.04x |
Competitor Companies of CGS by Market Capitalization
Companies near Cogstate Ltd in the global market cap rankings as of May 4, 2026.
Key companies related to Cogstate Ltd by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #926 globally with a market cap of $28.21 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #2225 globally with a market cap of $10.06 Billion USD ( AU$14.22 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2339 globally with a market cap of $9.34 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2447 globally with a market cap of $8.82 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #926 | Veeva Systems Inc Class A | NYSE:VEEV | $28.21 Billion | $171.60 |
| #2225 | Pro Medicus Ltd | AU:PME | $10.06 Billion | AU$136.16 |
| #2339 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $9.34 Billion | $55.00 |
| #2447 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $8.82 Billion | $52.58 |
Cogstate Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Cogstate Ltd's market cap moved from $70.96 Million to $ 291.33 Million, with a yearly change of 21.91%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$291.33 Million | +6.19% |
| 2025 | AU$274.33 Million | +116.27% |
| 2024 | AU$126.85 Million | -27.68% |
| 2023 | AU$175.40 Million | -26.28% |
| 2022 | AU$237.92 Million | -19.01% |
| 2021 | AU$293.75 Million | +120.00% |
| 2020 | AU$133.52 Million | +182.05% |
| 2019 | AU$47.34 Million | -34.40% |
| 2018 | AU$72.16 Million | -32.59% |
| 2017 | AU$107.05 Million | -27.35% |
| 2016 | AU$147.35 Million | +107.65% |
| 2015 | AU$70.96 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Cogstate Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $291.33 Million USD |
| MoneyControl | $291.33 Million USD |
| MarketWatch | $291.33 Million USD |
| marketcap.company | $291.33 Million USD |
| Reuters | $291.33 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Cogstate Ltd
Cogstate Limited, a neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide. It offers digital cognitive assessment, endpoint data quality (rater services), remote assessment, scientific consulting, healthcare cognitive screening, and research and academic collaboration solutions for various therapeutic areas, includ… Read more